Novo Nordisk (NVO) is scheduled to report fourth-quarter 2024 results on Feb. 5, 2025, before the opening bell. The Zacks Consensus Estimate for quarterly revenues in the to-be-reported quarter is pegged at 11.34billion,whilethesameforearningsispinnedat83centspershare.SeetheZacks EarningsCalendartostayaheadofmarket−makingnews.Inthepast60days,theZacksConsensusEstimateforNovoNordisk’s2024earningspershare(EPS)declinedfrom3.28 to $3.16. During the same time frame, the ...